AstraZeneca Pharma India Limited has received a certificate confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate, dated December 2, 2025, was issued by Integrated Registry Management Services Private Limited, the Registrar and Transfer Agent (RTA) for AstraZeneca. The company confirms adherence to regulations concerning dematerialization.
Regulation Compliance Confirmed
AstraZeneca Pharma India Limited confirms its compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This compliance is validated by a certificate received from Integrated Registry Management Services Private Limited (IRMSPL), the company’s Registrar and Transfer Agent (RTA).
Certificate Details
The certificate, dated December 2, 2025, confirms actions taken within 15 days of receiving security certificates from depository participants, ensuring adherence to dematerialization regulations for the period of November 1, 2025 to November 30, 2025.
Key Compliance Actions
As per the certificate, IRMSPL has confirmed that the securities mentioned in the certificates are listed on the stock exchanges where the earlier issued securities are listed. Furthermore, mutilated and cancelled certificates of security were forwarded by the participants, and the name of the depository has been substituted as the registered owner in the company’s records.
Source: BSE